Clinical Trial Update: A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fesoterodine for bladder overactivity in children with a neurogenic condition has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder Disorders
• Urinary Bladder Neurogenic Conditions

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Urinary Bladder, Neurogenic | Phase 3 | Status: COMPLETED | Results posted: 2021-02-02